Business Standard

Alembic Pharmaceuticals receives ANDA approval for Amantadine Hydrochloride Capsules

Image

Capital Market

From USFDA

Alembic Pharmaceuticals has received approval from USFDA for its ANDA for Amantadine Hydrochloride Capsules, USP, 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product Symmetrel Capsules, 100 mg of Endo Pharmaceuticals Inc.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 22 2017 | 9:28 AM IST

Explore News